hero section gradient
15 handpicked stocks

Streaming Profitability Revolution

Discover a carefully selected group of stocks positioned to benefit as streaming services shift from chasing subscribers to maximizing profits. These companies, handpicked by our analysts, represent the future of media as streaming platforms flex their pricing power and prioritize sustainable growth.

Author avatar

Han Tan | Market Analyst

Published on July 18

Your Basket's Financial Footprint

Market capitalisation breakdown and investor key takeaways for the 'Streaming Profitability Revolution' basket.

Key Takeaways for Investors:
  • Large-cap concentration suggests lower volatility and broader market tracking, likely offering greater stability than small-cap baskets.
  • Treat as a core portfolio holding for steady exposure, not a speculative growth position.
  • Expect gradual, long-term appreciation rather than short-term explosive gains; growth tends to be steady.
Total Market Cap
  • NFLX: $526.00B

  • ROKU: $14.36B

  • WBD: $50.33B

  • Other

About This Group of Stocks

1

Our Expert Thinking

The streaming industry is evolving from growth-at-any-cost to profit-focused business models. Peacock's third price increase in three years signals a turning point where established platforms can now confidently monetize their user bases through both subscription increases and ad-supported tiers.

2

What You Need to Know

This collection includes both direct streaming providers and the ad-tech companies powering their monetization strategies. As streaming matures, companies with strong content libraries and advertising capabilities are demonstrating significant pricing power, potentially leading to higher margins.

3

Why These Stocks

We've selected companies across the streaming value chain, from content creation to ad delivery and audience measurement. These businesses are strategically positioned to benefit from the industry's shift toward sustainable revenue optimization rather than subscriber acquisition at any cost.

Why You'll Want to Watch These Stocks

💰

The Price Hike Domino Effect

With Peacock's price increase setting a precedent, other streaming giants are likely to follow suit. This pricing power could translate into significantly improved profitability across the industry.

📈

From Subscribers to Profits

The streaming industry is making a historic pivot from "growth at all costs" to sustainable profitability. Companies mastering this transition may see their stock values reflect these improved business models.

📺

The Rise of Ad-Supported Streaming

As ad-supported tiers become increasingly important revenue sources, the companies powering this advertising technology stand to benefit enormously from this industry-wide transformation.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions